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ttp://dx.doi.org/10.1016/j.ajpath.2014.01.030The potential for intrahepatic bile duct (IHBD) regeneration in patients with bile duct insufﬁciency diseases
is poorly understood. Notch signaling and Hnf6 have each been shown to be important for the morpho-
genesis of IHBDs inmice. One congenital pediatric liver disease characterized by reduced numbers of IHBDs,
Alagille syndrome, is associated with mutations in Notch signaling components. Therefore, we investigated
whether liver cell plasticity could contribute to IHBD regeneration in mice with disruptions in Notch
signaling and Hnf6. We studied a mouse model of bile duct insufﬁciency with liver epithelial cellespeciﬁc
deﬁciencies in Hnf6 and Rbpj, a mediator of canonical Notch signaling. Albumin-Cre Hnf6ﬂox/ﬂox Rbpjﬂox/ﬂox
mice initially developed no peripheral bile ducts. The evolving postnatal liver phenotype was analyzed using
IHBD resin casting, immunostaining, and serum chemistry. With age, Albumin-Cre Hnf6ﬂox/ﬂox Rbpjﬂox/ﬂox
mice mounted a ductular reaction extending through the hepatic tissue and then regenerated communi-
cating peripheral IHBD branches. Rbpj and Hnf6 were determined to remain absent from biliary epithelial
cells constituting the ductular reaction and the regenerated peripheral IHBDs. We report the expression of
Sox9, a marker of biliary epithelial cells, in cells expressing hepatocyte markers. Tissue analysis indicates
that reactive ductules did not arise directly from preexisting hilar IHBDs. We conclude that liver cell
plasticity is competent for regeneration of IHBDs independent of Notch signaling via Rbpj and Hnf6.
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Indianapolis, IN.Studies have demonstrated that bipotential progenitors may
be present in the liver that are capable of giving rise to
hepatocytes and biliary epithelial cells (BECs).1e4 How-
ever, the in vivo capacity of speciﬁc stem, progenitor, or
liver epithelial cells to regenerate a functional intrahepatic
bile duct (IHBD) system, and whether endogenous hepatic
cells hold potential therapeutic beneﬁt to treat bile duct
insufﬁciency or ductopenic liver diseases, remains unknown.
In addition to human studies of Alagille syndrome (ALGS)
etiology, mouse models have elucidated the importance of
Notch signaling in IHBD morphogenesis.5e9 The Jagged1
ligand, expressed in portal vein mesenchyme, activates Notch
receptors on bipotential hepatoblasts to promote IHBD forma-
tion.6 The DNA-binding co-factor recombination signaling
binding protein immunoglobulin kappa J (Rbpj) is required for
canonical Notch signaling within hepatoblasts. Along with
Notch signaling, hepatocyte nuclear factor 6 (Hnf6) is also
important for BEC speciﬁcation of bipotential hepatoblasts
during embryonic development.10stigative Pathology.
.Previous work has demonstrated that the Albumin-
Creemediated11 hepatoblast-speciﬁc deletion of Rbpj12 and
Hnf613 produces a synergistic defect whereby Rbpj and
Hnf6 double knockout (DKO) mice are developmentally
unable to form peripheral IHBDs.14 Early in life, IHBD
paucity causes severe cholestasis, hepatic necrosis, and
ﬁbrosis in these mice. However, DKO mice eventually
generate BECs in reactive ductules.14
Walter et alHerein, we demonstrate that DKO mice are indeed
capable of forming communicating peripheral IHBDs sub-
sequent to the emergence of a ductular reaction. This ﬁnding
indicates that Notch and Hnf6 are together dispensable for
IHBD regeneration in adult mice, which may explain the
recovery of cholestasis that occurs in some patients with
ALGS while providing a new concept for investigation of
potential Notch-independent IHBD regenerative therapies.
Materials and Methods
Mouse Lines
DKO mice were generated by crossing Tg(Alb-cre)21Mgn
(Albumin-Cre),11 Rbpjtm1Hon (Rbpﬂox),12 and Onecut1tm1.1Mga
(Hnf6ﬂox)13 mouse lines. Mouse genotypes were conﬁrmed
by PCR using previously established primer pairs. All the
breeding and experimental procedures were performed with
approval from the Institutional Animal Care and Use Com-
mittees at Vanderbilt University (Nashville, TN) and Cin-
cinnati Children’s Hospital (Cincinnati, OH).
Resin Casting and Tissue Clearance
Retrograde resin injection of the common bile duct and tissue
clearance were performed as previously described.15 The left
liver lobes were photographed using anMZ16 FA stereoscope
(Leica Microsystems Inc., Buffalo Grove, IL) and a Retiga
4000R camera (QImaging, Surrey, BC, Canada).Table 1 Antibodies Used for Immunohistochemical Analysis
Antigen Dilution Host Company*
Primary antibodies
CK19 (TromaIII) 1:200 Rat DSHB
CK19 1:200 Mouse Dako
Cytokeratin, wide spectrum 1:300 Rabbit Dako
DBA-biotin 1:500 Vector La
EYFP (GFP) 1:500 Rabbit Novus
Glutamine synthetase 1:1000 Mouse BD Transd
HNF1b 1:2000 Goat Santa Cru
HNF4a 1:1000 Goat Santa Cru
HNF6 1:200 Rabbit Santa Cru
Ki-67 1:200 Mouse BD Pharm
RBPJ-k (T6709) 1:100 Rat Cosmo Bio
Sox9 1:500 Rabbit Millipore
Secondary antibodies
a rabbit-biotin 1:500 Donkey Jackson I
a rabbit-cy3 1:300 Donkey Jackson I
a rat-Alexa488 1:300 Donkey Jackson I
a rat-biotin 1:1000 Goat Jackson I
a goat-biotin 1:500 Donkey Jackson I
a mouse-biotin 1:500 Goat Jackson I
Streptavidin-cy2 1:300 Jackson I
Streptavidin-HRP 1:500 Vector La
*DSHB, Developmental Studies Hybridoma Bank, Iowa City, IA; Dako, Carpinteria
San Jose, CA; Santa Cruz Biotechnology, Santa Cruz, CA; BD Pharmingen, San Die
ImmunoResearch Laboratories, West Grove, PA.
ABC, avidin biotin complex; DAB, diaminobenzidine; FITC, ﬂuorescein isothioc
1480Immunohistochemical Analysis
Murine liver tissue was ﬁxed overnight at 4C in 4%
paraformaldehyde, processed, and embedded in parafﬁn.
Sodium citrate, pH 6, or antigen unmasking solution (Vector
Laboratories, Burlingame, CA) antigen retrieval was per-
formed in heat and at high pressure for 15 minutes. Sections
were incubated in primary antibody overnight at 4C and in
secondary antibody for 2 hours at room temperature in 1%
bovine serum albumin in PBS. Antibodies are listed in
Table 1. The following reagents were used for antibody
detection or ampliﬁcation: ApopTag kit (Millipore, Bill-
erica, MA), blue alkaline phosphatase substrate kit (Vector
Laboratories), diaminobenzidine substrate kit (Vector Lab-
oratories), TSA biotin (PerkinElmer, Waltham, MA), TSA
plus ﬂuorescein isothiocyanate (PerkinElmer), and Vectas-
tain ABC system (Vector Laboratories). Mayer hematoxylin
and bisbenzimide were used as counterstains. Images were
acquired using either an Axioplan 2 microscope (Carl Zeiss
MicroImaging GmbH, Jena, Germany) and a Retiga EXi
camera (QImaging) or a BX51 microscope and a DP71
camera (Olympus America Inc., Center Valley, PA).Serum Chemistry
Blood collected from postmortem mice was tested for serum
total bilirubin concentration by colorimetric end point assay
(Teco Diagnostics, Anaheim, CA).Retrieval Ampliﬁcation
Na citrate ABC; DAB (chromogenic)





z Na citrate ABC; TSAþFITC
z Na citrate ABC; TSAþFITC
z Na citrate ABC; TSAþFITC
ingen Na citrate










, CA; Novus, Novus Biologicals, Littleton, CO; BD Transduction Laboratories,
go, CA; Cosmo Bio Co. Ltd., Tokyo, Japan; Millipore, Billerica, MA; Jackson
yanate.
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IHBD Regeneration without Notch or HNF6Statistical Analysis
A one-tailed unpaired Student’s t-test was used to analyze
differences.
Results
Adult Peripheral IHBDs Form in the Absence of Rbpj
and Hnf6
To examine IHBD regeneration, we used the bile duct
insufﬁciency Albumin-Cre Rbpjﬂox/ﬂox Hnf6ﬂox/ﬂox (DKO)
mouse model.14 On postnatal day (P) 15, DKO mice lacked
peripheral IHBDs but had normal-appearing hilar and
extrahepatic bile ducts. DKO mice also demonstrated
extensive hepatocyte necrosis on P15 (Figure 1B). How-
ever, by P60, DKO mice displayed a cytokeratin 19
(CK19)þ ductular reaction (Figure 1D). On P120, DKO
mice exhibited a reduction in reactive ductules and dis-
played patent regenerated peripheral IHBDs (Figure 1F).
To quantify the extent of IHBD paucity and regenera-
tion, hilar and peripheral IHBD branches in DKO andFigure 1 DKO mice exhibit histologic recovery of peripheral IHBD
paucity by P120. Parafﬁn sections of DKO and control (lacking Albumin-Cre
transgene) mouse livers on P15 (A and B), P60 (C and D), and P120 (E and F)
were immunostained for CK19 to mark BECs and were counterstained with
Mayer hematoxylin. On P15, control mice had well-formed IHBDs (A; arrow),
whereas DKO mice lacked peripheral IHBDs and exhibited areas of focal
necrosis (B; arrowheads). C and D: On P60, DKO mice displayed a large in-
crease in peripheral CK19þ BECs (D, arrows), which form reactive ductules
unlike the control mice at P60 with patent IHBDs (C, arrow). E and F: By
P120, many of the reactive ductules resolved to patent peripheral IHBDs in
DKO mice (E, arrow), similar to control mice (F, arrow). Scale barZ 100 mm.
Details regarding serum total bilirubin levels and histologic severities are
provided in Supplemental Table S1.
Figure 2 DKO mice display a lack of peripheral IHBDs on P15 and partial
recovery of peripheral IHBDs on P120. P15 and P120 control and DKO mouse
liver sections were stained for CK19 and were stained with the lectin DBA,
which marks only BECs composing the hilar IHBDs. A: On P15, DKO mice
showed a statistically signiﬁcant decrease in the number of DBA peripheral
IHBDs per area but no change in DBAþ hilar IHBDs. B: On P120, some DKO
mice displayed a full recovery in the number of DBA peripheral IHBDs per
area, whereas some DKO mice did not recover to control levels. Compared
with control, there was no statistically signiﬁcant difference in peripheral or
hilar IHBDs at P120. The two P120 DKO mice that exhibited recovery in
peripheral IHBDs had normal serum total bilirubin levels of 0 and 1.12 mg/
dL; the two P120 DKO mice that did not exhibit full recovery had serum total
bilirubin levels of 27.1 and 1.27 mg/dL (see Supplemental Table S1 for
further details of DKO phenotypes). Three to four animals were analyzed for
each genotype at each time (represented by black circles). The horizontal
lines represent the average IHBDs per genotype. At least six (P15) or three
(P120) sections of liver and a minimum area of 63 mm2 (P15) or 56 mm2
(P120) of liver tissue was analyzed for each animal. **P < 0.01.
The American Journal of Pathology - ajp.amjpathol.orgcontrol mice were counted in tissue sections on P15 and
P120. Among the CK19þ cells, localization of the lectin
dolichos biﬂorus agglutinin (DBA) was used to deﬁne and
distinguish hilar from peripheral IHBDs. On P15, DKO
mice displayed no difference in the number of hilar IHBD
branches (Figure 2A). However, there was a dramatic and
signiﬁcant decrease in the number of peripheral IHBD
branches in DKO mice compared with controls. On P120,
there remained no difference in the number of hilar IHBD
branches between control and DKO mice (Figure 2B). On
P120, some DKO mice displayed a complete recovery in
peripheral IHBD branches to control levels; however,
some DKO mice still exhibited a reduction in the number1481
Figure 3 Three-dimensional hepatic architecture improves in DKO mice.
Liquid resin/catalyst mixture was injected retrograde into the common bile
duct to generate a cast of the communicating IHBD structure in P60 and
P120 control (A and B) and DKO (C and D) mice. C: On P60, the DKO cast
exhibited a severe lack of communicating peripheral IHBDs. D: However, by
P120, the DKO IHBD structure exhibited partial recovery with a visual in-
crease in the number of peripheral IHBD branches. Total bilirubin levels for
the representative DKO IHBD resin cast is displayed (C and D). Scale barZ
1 mm. Details regarding serum total bilirubin levels and cast severities are
provided in Supplemental Table S1.
Figure 4 DKO mice do not express Hnf6 in BECs or hepatocytes. P60
and P120 control and DKO mouse liver sections were stained for Hnf6 (red),
CK19 (green), and Hoechst (blue). In P60 (A) and P120 (C) control mice,
Hnf6 was present in hepatocytes and BECs (red arrows). In P60 (B) and
P120 (D) DKO mice, Hnf6 was not detected in hepatocytes or BECs in either
reactive ductules or remodeled IHBDs (white arrows). Scale barZ 100 mm.
Walter et alof peripheral IHBD branches compared with controls
(Figure 2B).
We performed IHBD resin casting15 to determine whether
the peripheral IHBDs observed in the sections contributed to
the three-dimensional communicating IHBD architecture.
On P60 in DKO mice, only the hilar branches of the IHBD
communicated with the extrahepatic bile duct system
(Figure 3C). However, DKO mice on P120 displayed re-
generated peripheral IHBD branches (Figure 3D). P120
DKO mice also demonstrated recovery from cholestasis, as
measured by total bilirubin levels in serum (Supplemental
Table S1). There was some variation among the DKO mice
in terms of extent of IHBD paucity in casts and in total
bilirubin levels (Supplemental Table S1). Representative
cast images with the corresponding total bilirubin levels are
shown at each time point (Figure 3): for P60 DKO mice, the
most common phenotype was hilum cast, and for P120
DKO mice, the most common phenotype was moderate.
BECs in Ductular Reactions and Regenerated Peripheral
IHBDs Do Not Express Rbpj or Hnf6
To determine whether the ductular reaction and regeneration
of peripheral IHBDs can truly occur without Rbpj and Hnf6,
we examined the expression of each protein in BECs. If the
recovery is due to either an expansion of BECs that retain
Rbpj and/or Hnf6 expression or a conversion of cells from a
noneAlbumin-Creeexpressing cell lineage into BECs, we
would expect to ﬁnd that all or most BECs on P60 and P120
will retain expression of one or both of these proteins.1482We performed immunohistochemical analysis for Hnf6 in
P60 and P120 DKO and control mice. Hnf6 was present
throughout the tissue in hepatocytes and BECs on P60 and
P120 in control mice (Figure 4, A and C). In DKO mice,
however, hepatocytes and BECs expressed no detectable Hnf6
on P60 or P120, demonstrating that the BECs constituting
reactive ductules and regenerated peripheral IHBDs are
formed in the absence of Hnf6 protein (Figure 4, B and D).
To determine whether Rbpj is present in reactive and
regenerated peripheral BECs, we performed immunostain-
ing for Rbpj protein. Rbpj is not only expressed in cells with
activated Notch signaling but also is ubiquitously expressed
in all cell types.16 The levels of Rbpj protein are normally
very low in liver epithelial cells, and the protein can be
detected only with multiple steps of ampliﬁcation for im-
munostaining performed on parafﬁn-embedded tissue. In
control mice on P60 and P120, Rbpj was consistently
observed in wide spectrum cytokeratinepositive BECs and
in the surrounding stromal cells (Figure 5, A and C). On P60
and P120, most BECs present in either reactive ductules or
regenerated IHBDs expressed no detectable Rbpj protein.
Only very rare BECs that express Rbpj were present in the
liver on P60 and P120 (Figure 5, B and D). We detected no
indication that undeleted populations of BECs are prefer-
entially expanding and contributing to regenerated IHBDs
in DKO mice.Ductular Reactions Occur Surrounding All Peripheral
Portal Veins
To assess the extent of the ductular reaction and IHBD
regeneration over time in the hepatic architecture context,
we immunostained for CK19 to mark BECs and forajp.amjpathol.org - The American Journal of Pathology
Figure 5 DKO mice do not express Rbpj in nearly all BECs of reactive
ductules and IHBDs. P60 and P120 control and DKO liver sections were
stained for wide spectrum cytokeratin (wsCK; red), Rbpj (green), and
Hoechst (blue). Rbpj was expressed in all cells and BECs in control mice on
P60 (A) and P120 (C). In P60 (B) and P120 (D) DKO mice, nearly all wsCKþ
BECs in reactive ductules and IHBDs expressed no Rbpj protein. Rare Rbpjþ
wsCKþ BECs are marked with white arrowheads. Scale bar Z 50 mm.
Figure 6 Atypical ducts arise surrounding all peripheral portal vein
branches by P60 and are partially resolved by P120. P60 and P120 control
and DKO mouse liver sections were stained for glutamine synthetase (green),
CK19 (red), and Hoechst (blue). Glutamine synthetase expression de-
marcates hepatocytes adjacent to central versus portal veins at low (A, B, E,
and F) and high (C, D, G, and H) magniﬁcations. B and D: CK19þ reactive
ductules appeared in P60 DKO mice throughout the liver in all regions sur-
rounding peripheral portal vein branches. F and H: In P120 DKO mice,
reactive ductules largely resolved and patent bile ducts formed adjacent to
peripheral portal veins throughout the tissue. Scale bars: 500 mm.
IHBD Regeneration without Notch or HNF6glutamine synthetase to mark pericentral hepatocytes. This
allowed us to discriminate between portal veins, where
IHBDs were normally associated, and central veins
(Figure 6, A, C, E, and G). If new BECs arise from rare cells
in the liver, for example, a small number of cells that retain
Rbpj and/or Hnf6 expression, we would expect to see
localized expansions of CK19þ cells. Instead, we saw that
on P60, the CK19þ ductular reaction extended throughout
the liver, with reactive ductules surrounding all the periph-
eral portal vein branches (Figure 6, B and D). On P120, the
CK19þ reactive ductules resolved and patent IHBDs were
present in regions of glutamine synthetaseenegative
hepatocyte-associated portal veins (Figure 6, F and H).
Reactive BECs Are Not Derived from Hilar DBAþ IHBDs
To explore the hypothesis that cells contributing to preex-
isting IHBDs give rise to ductular reactions and peripheral
IHBDs, we analyzed the relationship between CK19-
expressing cells and DBAþ hilar ducts. We examined a
time point between P15, when no peripheral BECs are
present, and P60, when a full ductular reaction has devel-
oped; at P30, reactive CK19þ BECs just began to appear
(Figure 7, BeF, compared with Figure 6). To determine
whether these emerging CK19þ reactive BECs were coming
from differentiated hilar BECs, we assessed the expression
of CK19 and DBA in three dimensions on serial liver sec-
tions. We examined serial sections of the P30 DKO mouse
liver in areas where CK19þ reactive BECs were found.
These cells existed in small clusters that extend in three
dimensions but do not juxtapose DBAþ hilar IHBDs on any
spatial axis, as visible in the image captured from a hilar
region (Figure 7A). These results suggest that the initialThe American Journal of Pathology - ajp.amjpathol.orgCK19þ reactive BECs are not emerging directly from
formed hilar IHBDs.
Next, we examined expression of the BEC marker sex-
determining region Yerelated high-mobility group box
transcription factor 9 (Sox9). Normally, Sox9 expression
is activated during ductal plate differentiation of BECs,17
expressed in mature BECs, enriched in adult mouse he-
patic progenitor cell populations,1 and has been demon-
strated to be a marker of hepatocyte-to-BEC conversion.18
To examine the spatial relationships among the Sox9þ
cells, emerging CK19þ reactive BECs, and DBAþ IHBDs,
we performed immunostaining for Sox9 and CK19 on
serial liver sections in P30 DKO mice (Figure 7, GeL).
Sox9 was expressed widely throughout the hepatic tissue
of DKO mice. Sox9þ cells (Figure 7, GeL) were present
outside of CK19þDBAþ hilar IHBDs (Figure 7G) and1483
Figure 7 Reactive CK19þBECs emerge juxtaposed to Sox9þ intermediate cells but not juxtaposed to DBAþ hilar IHBDs. OnP30, hilar IHBDsbound the lectin DBA
(A and G; green arrowheads). Serial sections of a P30 DKO mouse liver were stained for CK19 (green) and DBA (red; AeF) or Sox9 (red; GeL), and Hoechst (blue).
CK19þ reactive BECs were found in small clusters that extended in three dimensions. These BECs, representing the beginning of the ductular reaction and formation
of peripheral IHBDs, were found in areas in which there was close proximity of Sox9þ intermediate cells but not juxtaposed to DBAþ hilar IHBDs (BeF; white
arrowheads). Sox9þCK19 cells (GeL; red arrowheads) were frequently observed in the vicinity of reactive BECs (HeL;white arrowheads). Scale barZ 100 mm.
Walter et alCK19þDBA peripheral BECs (Figure 7, BeF).
CK19þDBA peripheral BECs were consistently found in
close spatial association with Sox9þCK19 cells.
Although small clusters of Sox9þ cells existed in close
proximity to DBAþ IHBDs, they were already widespread
in the peripheral tissue by P30.
To further assess whether these Sox9þ cells may be
arising from hilar IHBDs, we also analyzed the spatial
relationship between Sox9þ cells and DBAþ hilar IHBDs
through immunoﬂuorescence on serial liver sections on P15
(Figure 8). Sox9þ cells were found surrounding necrotic
lesions (Figure 8, BeF). On P15, Sox9þ cells extended in
three dimensions surrounding areas of focal necrosis. The
areas of focal necrosis were apparent by cell morphology
and the sticking of the lectin DBA. We found that these
areas of Sox9þ cells did not juxtapose patent hilar IHBDs inFigure 8 Sox9þ intermediate cells in P15 DKO mice do not arise from hilar BEC
(green), and Hoechst (blue). A: On P15, hilar IHBDs bound the lectin DBA. BeF:
with dashed lines) were followed through at least 72 mm of tissue. Sox9þ interme
any tissue depth.
1484any area examined. Although this analysis does not deﬁni-
tively determine that the Sox9þ cells do not arise from
DBAþ IHBDs, these data strongly support this conclusion.
DKO Mice Exhibit Sox9þ Intermediate Cells
To assess the cellular identity of the observed Sox9þ cells in
DKO mice, we performed immunohistochemical analysis
for Sox9. Sox9 expression was observed in cells that his-
tologically appear as BECs in P15 and P60 control livers
(Supplemental Figure S1, A and G). In P15 DKO mice,
Sox9 was seen not only in IHBDs (Supplemental
Figure S1F) but also in non-IHBD cells surrounding
necrotic lesions throughout the liver (Supplemental
Figure S1E). These cells morphologically resemble hepa-
tocytes. Although they are found near focal necrotic regions,s. Serial sections of a P15 DKO mouse liver were stained for Sox9 (red), DBA
Areas of Sox9þ intermediate cells surrounding focal necrotic areas (circled
diate cells did not juxtapose or spatially associate with DBAþ hilar ducts at
ajp.amjpathol.org - The American Journal of Pathology
IHBD Regeneration without Notch or HNF6these Sox9þ cells did not undergo apoptosis (Supplemental
Figure S2). In P60 DKO mice, Sox9 expression was found
in IHBDs (Supplemental Figure S1L) and in the liver pa-
renchyma in cells that morphologically resembled hepato-
cytes (Supplemental Figure S1K).
We further characterized the identity of Sox9þ cells by
performing co-immunostaining with markers of BECs or
hepatocytes. In DKO mice on P15, Sox9þ cells surrounding
necrotic areas co-expressed the hepatocyte marker Hnf4a
(Supplemental Figure S3A) and did not express the BEC
markers Hnf1b (Supplemental Figure S3B) and CK19
(Supplemental Figure S3C). The Sox9þ cells displayed cell
fate markers of the hepatocyte marker Hnf4a and the BEC
marker Sox9 and, therefore, represented a population of
intermediate cells. In DKO mice on P60, Sox9 was again
found in intermediate cells co-expressing Hnf4a (Supple-
mental Figure S3D) and in Hnf1bþ and CK19þ reactive
BECs (Supplemental Figure S3F).
To determine whether any of these newly formed reactive
CK19þ BECs observed in P30 DKO mice still expressed
hepatocyte markers, we assessed the expression of Hnf4a
and CK19 at this time point (Supplemental Figure S4). We
did ﬁnd a few of the newly formed reactive CK19þ BECs to
express very low levels of Hnf4a (Supplemental
Figure S4B). However, we did not observe co-expression of
CK19 and Hnf4a in the prevalent reactive BECs present in
DKO mice on P51 (Supplemental Figure S4D).
Discussion
Sox9þ BECs and a Communicating IHBD System Are
Able to Form without Hnf6 and Notch Signaling via
Rbpj
The involvement of Notch and Hnf6 in ductal plate IHBD
development has been well characterized.6,8,10,17 During
ductal plate morphogenesis, hepatoblasts surrounding the
portal vein are speciﬁed as BECs, become polarized, and
remodel into a luminal IHBD structure.17 The initial pe-
ripheral IHBD paucity observed in DKO mice indicates that
ductal plate IHBD morphogenesis cannot occur without
Notch signaling and Hnf6 (Figure 1). However, the regen-
eration of peripheral IHBDs in DKO mice (Figure 2) despite
the absence of Rbpj and Hnf6 protein from nearly all BECs
and hepatocytes (Figures 4 and 5)14 excludes an absolute
cell-autonomous requirement of these genes for BEC dif-
ferentiation during injury.
Recent studies have demonstrated that the cell-autonomous
overactivation of Notch signaling is capable of driving
hepatocyte-to-BEC conversion and that deleting Rbpj impairs
efﬁcient hepatocyte-to-BEC conversion in liver injury
models.18,19 For example, Yanger et al18 demonstrated that
deleting Rbpj decreases the number of Sox9þ lineage-labeled
hepatocytes arising during liver injury but does not completely
block the response. Similarly, inhibiting Notch signaling
reduced the extent of the ductular reaction mounted inThe American Journal of Pathology - ajp.amjpathol.orgresponse to injury.20 The present data add to this story through
the indication that Notch is not absolutely required. In a Notch
loss model, it may take longer to reach intracellular thresholds
to activate Sox9 expression. We hypothesize that one or more
signaling pathways may converge to activate Sox9 expression
and, in coordination with Sox9, overcome the loss of Notch
signaling in the DKO model. Contributing signaling mole-
cules may originate from inﬁltrating immune cells to initiate
the expression of Sox9 localized around necrotic lesions.
There is precedent for immune and endothelial cells commu-
nicating with the liver epithelium during injury21,22 to promote
liver regeneration. Previous studies investigating hepatocyte-
to-BEC conversion in mice and rats have identiﬁed Akt,
HGF, EGF, and PI3K as potential mediators of the trans-
differentiation process23,24 in a Notch signalingecapable
background. Further studies are required to determine which
extracellular and intracellular signaling pathways are driving
the Notch-independent alternative BEC differentiation mech-
anism observed in DKO mice.
Although Sox9þ intermediate cells are observed in the
Notch loss and Notch overactivation models, the molecular
regulation may be different. In Notch overactivation, the
biliary cell marker Hnf1b becomes activated in hepatocytes
co-expressing Hnf4a18; however, the co-expression of these
markers is not observed in the DKO mouse model, where
Hnf1b is expressed in Sox9þ cells that have already down-
regulated Hnf4a (Supplemental Figure S3). This suggests
that the regulation of Sox9 expression may be quite different
in the presence or absence of Notch signaling. The two
different models may have complementary clinical impli-
cations, with Notch overactivation modeling carcinogenesis
and the Notch loss more closely resembling a chronic
cholestatic disease injury.
Reactive BECs that Arise in Peripheral Regions
Originate from Liver Epithelium but Not from Hilar
IHBDs
There are several possible origins of the peripheral reactive
BECs and regenerated IHBDs in the DKO mouse models,
including differentiated DBAþ hilar IHBDs, extrahepatic
bile ducts, extrahepatic bile ducteassociated peribiliary
glands,25,26 hepatocytes,18,23,27 mesenchymal/stellate cells,28,29
endothelial cells,30 and hematopoietic cells.31 Because we
are not able to perform Cre-mediated lineage tracing in this
Cre-generated genetic deﬁciency model, we cannot deﬁni-
tively rule out any of these possibilities. However, the
ﬁnding that almost every BEC observed in P60 and P120
DKO mice was deleted for Rbpj and Hnf6 strongly indicates
that new BECs come from an Albumin-Creederived intra-
hepatic cell and not from a nonhepatic source (Figures 4 and
5). This makes it highly unlikely that the new BECs would
originate from the extrahepatic bile ducts, peribiliary glands,
mesenchymal cells, endothelial cells, or hematopoietic cells.
Although the existing hilar IHBDs on P15 are restricted to
the proximal base of the liver, the reactive BECs are present1485
Walter et althroughout the liver periphery. It is difﬁcult to imagine how
cells from the hilar IHBD would distribute throughout the
liver periphery, either by cell migration or proliferation, in
the time it takes before reactive BECs are seen throughout
the tissue (Figure 6). This dissuades the idea that the new
BECs are arising from the existing Albumin-Creederived
IHBDs. Similarly, the observation that the ﬁrst peripheral-
appearing Sox9þ CK19þ BECs that form reactive ductules
emerge in the parenchyma, not juxtaposing differentiated
DBAþ hilar IHBDs, strongly indicates that the BECs of the
ductular reaction are arising through a de novo differentiation
process and are not originating from preexisting formed hilar
IHBDs (Figures 7 and 8).
A remaining possibility is that the new BECs arise from
Albumin-Creederived hepatocytes. This idea is supported
by three observations. First, the BECs contributing to the
ductular reaction and the regenerated peripheral IHBDs are
deﬁcient for Rbpj and Hnf6. Second, we observed expres-
sion of Sox9, a BEC marker, in intermediate Hnf4aþ cells
of the DKO liver (Supplemental Figure S3). Sox9 has pre-
viously been shown to be an early marker of interlineage
conversion18 and may mark cells beginning a conversion
process in the DKO model as well. Indeed, new peripherally
localized BECs are found in areas dense with Sox9þ cells
that do not express CK19 (Figure 7). Third, a few cells
contributing to the newly formed CK19þ reactive ductules
at P30 in DKO mice expressed very low levels of the he-
patocyte marker Hnf4a (Supplemental Figure S4). This
overlapping expression was not detectable at P51 in the
reactive BECs, providing evidence of hepatocyte-associated
gene expression in CK19þ cells at the early stages of IHBD
remodeling in the DKO mouse model. Therefore, it remains
formally possible that the Sox9þ intermediate cells give rise
to the new CK19þ BECs.
The Combined Loss of Rbpj and Hnf6 Has a Synergistic
Effect on the Injury Condition that May Be Crucial for
the Observed Regenerative Response
The liver-speciﬁc single deletion of Rbpj (Rbpj KO) de-
creases the number of IHBD branches, and no recovery in
IHBD branch number was found to occur with age in that
model.32 We propose three explanations for the difference
in regenerative capacity between Rbpj KO and DKO mice:
i) the more severe degree of hepatic injury observed in DKO
mice is required to induce the proper stimulus or signal to
drive adult IHBD regeneration; ii) the Rbpj KO mice un-
dergo a low level of IHBD regeneration and replenishment
that is below the resolution of our previous resin cast
microecomputed tomographic analysis (20 mm limita-
tion)32; or iii) the absence of Hnf6 in a Notch-deﬁcient
background is required for adult IHBD regeneration. The
presence of Sox9þ intermediate cells in Rbpj KO mice19
(T.J.W. and S.S.H., unpublished data) indicates that the
absence of Hnf6 is not required for the emergence of in-
termediate cells, but it remains possible that Hnf6 functions1486to inhibit later stages of IHBD regeneration. Hepatic Hnf6
levels have been found to decrease after bile duct ligation in
mice, and forced overexpression of Hnf6 inhibits IHBD
regeneration through decreasing BEC proliferation.33 Thus,
Hnf6 may potentially play an active role in mediating IHBD
regeneration. This is an active area of investigation in our
laboratory. At this time, we cannot rule out any of these
explanations with certainty.
De Novo BEC Differentiation May Be a Common and
Targetable Phenomenon in Human Liver Disease and
Regeneration
The occurrence of BEC marker expression in intermediate
cells in human liver disease samples has previously been
observed in cases of hepatocellular injury and ﬁbrosis.18
These ﬁndings indicate that the intermediate cells seen in the
DKO mouse model may be a common feature of cholestatic
liver diseases (Supplemental Figures S1 and S3), situations
of IHBD regeneration, and are especially relevant to the
Notch-associated disease ALGS.34 Histopathologic studies
have shown that patients with ALGS display large accu-
mulations of intermediate hepatobiliary cells that co-express
hepatocyte and BEC markers.35e37 Additional studies are
required to determine whether Sox9þ intermediate cells
correlate with ALGS disease severity or outcome.
To date, Hnf6 mutations have not been found to
contribute to ALGS. However, the loss of Hnf6 greatly in-
creases the severity of injury caused by Rbpj deletion in
mouse liver.14 This ﬁnding may reﬂect how epigenetic
changes of Hnf6, and/or genetic or epigenetic changes of
other liver genes, could modulate Notch loss in patients with
ALGS and inﬂuence disease severity between patients.
Further detailed analysis is required to characterize the role
of other genes in modulating the varied disease severity and
recovery in patients with ALGS.
The present ﬁndings in DKO mice demonstrate that new
BECs may be able to alleviate cholestasis in patients with
ALGS despite the persistent Notch impairment. Hopefully,
further investigation on the potential of intermediate cells in
mice and more in-depth studies analyzing human tissues
will identify alternative signaling mechanisms that may be
used therapeutically to drive Notch-independent IHBD
regeneration in patients, especially given the potential
cholangiocellular carcinogenic outcome of Notch
overactivation.23,38Acknowledgments
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